StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$29.52+0.43 (+1.48%)

Close on Nov 17, 2026Market cap $1.11BP/E –Yield –

Harrow operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Harrow's operating cash flow for the twelve months ending Jun 30, 2026 was $6.25M, up 54.9% year over year. For fiscal 2025 it was $43.86M. The highest annual figure on record is $43.86M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$43.86M–
FY2024Dec 31, 2024-$22.20M-678.2%
FY2023Dec 31, 2023$3.84M+125.2%
FY2022Dec 31, 2022$1.71M-66.5%
FY2021Dec 31, 2021$5.08M–
FY2020Dec 31, 2020-$1.10M-215.8%
FY2019Dec 31, 2019$950.00K+38.3%
FY2018Dec 31, 2018$687.00K–
FY2017Dec 31, 2017-$8.80M–
FY2016Dec 31, 2016-$11.22M–
FY2015Dec 31, 2015-$11.14M–
FY2014Dec 31, 2014-$7.06M–
FY2013Dec 31, 2013-$4.44M–
FY2012Dec 31, 2012-$1.90M–
FY2011Dec 31, 2011-$291.16K–
FY2010Dec 31, 2010-$2.30M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.76M–
Q1 FY2026Mar 31, 2026-$8.99M-145.7%
Q4 FY2025Dec 31, 2025$8.41M–
Q3 FY2025Sep 30, 2025$16.59M+462.1%
Q2 FY2025Jun 30, 2025-$803.00K–
Q1 FY2025Mar 31, 2025$19.67M–
Q4 FY2024Dec 31, 2024-$17.78M-304.5%
Q3 FY2024Sep 30, 2024$2.95M–
Q2 FY2024Jun 30, 2024-$2.75M-160.1%
Q1 FY2024Mar 31, 2024-$4.63M–
Q4 FY2023Dec 31, 2023$8.70M–
Q3 FY2023Sep 30, 2023-$1.21M–
Q2 FY2023Jun 30, 2023$4.57M-6.0%
Q1 FY2023Mar 31, 2023-$8.21M-949.4%
Q4 FY2022Dec 31, 2022-$3.71M–
Q3 FY2022Sep 30, 2022-$410.00K–
Q2 FY2022Jun 30, 2022$4.86M-10.7%
Q1 FY2022Mar 31, 2022$967.00K-69.9%
Q4 FY2021Dec 31, 2021-$1.49M–
Q3 FY2021Sep 30, 2021-$2.08M-177.8%
Q2 FY2021Jun 30, 2021$5.44M–
Q1 FY2021Mar 31, 2021$3.21M–
Q4 FY2020Dec 31, 2020-$566.00K-134.3%
Q3 FY2020Sep 30, 2020$2.67M–
Q2 FY2020Jun 30, 2020-$2.65M-414.1%
Q1 FY2020Mar 31, 2020-$550.00K–
Q4 FY2019Dec 31, 2019$1.65M–
Q3 FY2019Sep 30, 2019-$70.00K-121.7%
Q2 FY2019Jun 30, 2019$844.00K-38.2%
Q1 FY2019Mar 31, 2019-$1.48M–
Q4 FY2018Dec 31, 2018-$36.00K–
Q3 FY2018Sep 30, 2018$323.00K–
Q2 FY2018Jun 30, 2018$1.37M–
Q1 FY2018Mar 31, 2018-$965.00K–
Q4 FY2017Dec 31, 2017-$294.00K–
Q3 FY2017Sep 30, 2017-$2.22M–
Q2 FY2017Jun 30, 2017-$2.31M–
Q1 FY2017Mar 31, 2017-$3.98M–
Q4 FY2016Dec 31, 2016-$2.24M–
Q3 FY2016Sep 30, 2016-$3.91M–

More Harrow figures

See a number that looks wrong?